Skip to content

In the U.S., one person dies every two minutes from sepsis. Many organizations have initiated programs around caring for the septic patient that falls short of desired outcomes. The complexity of the disease, variability in presentation of the patient, and the skill and knowledge level of the provider makes this core measure distinctly di­fferent and potentially a greater challenge to implement. This webinar will focus on taking the learner through a four-tiered strategy to identify patients early in the disease and manage them based on the latest evidence. Health equity and disparities in sepsis care will also be discussed, as well as key implementation strategies for hard wiring the clinical and process behaviors. Barriers with reliable actions to reduce their impact will be described and participants will have the opportunity to identify gaps between the evidence and their hospitals program.

Learning Objectives

  1. Summarize the four-tier process for e­ffective sepsis program development
  2. Examine evidence for the sepsis bundles and share proven strategies to resolve barriers in implementation and measurement
  3. Identify gaps between the evidence and your hospital’s sepsis program

Featured Speaker:

Pat Posa RN, BSN, MSA, CCRN-K, FAAN

Quality and Patient Safety Program Manager for UH/CVC

Michigan Medicine

Target Audiences

Sepsis coordinators/leads, educators, clinical nurse specialist, acute care nurse practitioners, case managers, quality managers and directors

Since their initial emergency authorization in November, monoclonal antibodies have been an important weapon in the fight against COVID-19. These products have proven to be effective at preventing hospitalization and death due to COVID-19 in some of the highest risk patients. This presentation will provide an overview of these products, the data behind their emergency authorization, and the clinical considerations around their use.

Antimicrobial resistance may have increased during COVID-19 pandemic due to the medications being used to treat the virus including steroids and other immune-suppressive medications, longer hospital length of stay, ICU length of stay, and duration of mechanical ventilator. During East Alabama Medical Center’s (EAMC) annual review of their antibiogram, the antimicrobial stewardship and infection prevention teams discovered dramatic changes in hospital-acquired infections as well as increasing resistance patterns. Join this webinar to learn how the team at EAMC further stratified their data and made significant changes to recommended antimicrobials.